Prospects of Immune Checkpoint Modulators in the Treatment of Glioblastoma

Nature Reviews Neurology - United Kingdom
doi 10.1038/nrneurol.2015.139
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model

Cancer immunology research
Cancer ResearchImmunology
2015English

Immune Checkpoint Inhibitors in the Treatment of Virus-Associated Cancers

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

624. Immunovirotherapy Combined With Immune Checkpoint Inhibitors for Treating Glioblastoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Role of Immune Checkpoint Inhibitors in Gastrointestinal Cancer Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors

Neurotherapeutics
NeurologyPharmacology
2017English

Crosslink Between Temozolomide and PD-L1 Immune-Checkpoint Inhibition in Glioblastoma Multiforme

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Triplet CFTR Modulators: Future Prospects for Treatment of Cystic Fibrosis

Therapeutics and Clinical Risk Management
2018English

Treatment- And Immune-Related Adverse Events of Immune Checkpoint Inhibitors in Advanced Lung Cancer

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy